XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Previously reported
Common Stock
Common Stock
Previously reported
Common Stock
Revision of prior period, adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Previously reported
Additional Paid-in Capital
Revision of prior period, adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Previously reported
Accumulated Deficit
Accumulated Deficit
Previously reported
Balance as at beginning at Dec. 31, 2022 $ (94,929) [1] $ (94,929) $ 2 [1] $ 128 $ (126) $ 434,116 [1] $ 433,990 $ 126 $ (1,862) [1] $ (1,862) $ (527,185) [1] $ (527,185)
Balance as at beginning (in shares) at Dec. 31, 2022     23,861,000 [1] 127,761,000 (103,900,000)              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock from option exercises [1] 1         1            
Issuance of common stock from option exercises (in shares) [1]     5,000                  
Stock-based compensation 2         2            
Foreign currency translation adjustment 674               674      
Net loss (1,393)                   (1,393)  
Balance as at end at Mar. 31, 2023 [1] (95,645)   $ 2     434,119     (1,188)   (528,578)  
Balance as at end (in shares) at Mar. 31, 2023 [1]     23,866,000                  
Balance as at beginning at Dec. 31, 2022 (94,929) [1] (94,929) $ 2 [1] $ 128 $ (126) 434,116 [1] 433,990 126 (1,862) [1] (1,862) (527,185) [1] (527,185)
Balance as at beginning (in shares) at Dec. 31, 2022     23,861,000 [1] 127,761,000 (103,900,000)              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Foreign currency translation adjustment 1,386                      
Net loss (12,306)                      
Balance as at end at Sep. 30, 2023 [1] (105,746)   $ 3     434,218     (476)   (539,491)  
Balance as at end (in shares) at Sep. 30, 2023 [1]     24,075,000                  
Balance as at beginning at Mar. 31, 2023 [1] (95,645)   $ 2     434,119     (1,188)   (528,578)  
Balance as at beginning (in shares) at Mar. 31, 2023 [1]     23,866,000                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock from option exercises [1] 4         4            
Issuance of common stock from warrant exercise (in shares) [1]     33,000                  
Issuance of common stock from conversion of convertible promissory notes and accrued interest [1] 72         72            
Issuance of common stock from conversion of convertible promissory notes and accrued interest (in shares) [1]     4,000                  
Stock-based compensation 3         3            
Foreign currency translation adjustment 175               175      
Net loss (6,567)                   (6,567)  
Balance as at end at Jun. 30, 2023 [1] (101,958)   $ 2     434,198     (1,013)   (535,145)  
Balance as at end (in shares) at Jun. 30, 2023 [1]     23,903,000                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock from option exercises [1] 18   $ 1     17            
Issuance of common stock from option exercises (in shares) [1]     171,000                  
Issuance of common stock from conversion of convertible promissory notes and accrued interest (in shares) [1]     1,000                  
Stock-based compensation 3         3            
Foreign currency translation adjustment 537               537      
Net loss (4,346)                   (4,346)  
Balance as at end at Sep. 30, 2023 [1] (105,746)   $ 3     434,218     (476)   (539,491)  
Balance as at end (in shares) at Sep. 30, 2023 [1]     24,075,000                  
Balance as at beginning at Dec. 31, 2023 $ (115,437) [2] (115,437) $ 3 [2] $ 129 $ (126) 435,752 [2] 435,626 126 (1,538) [2] (1,538) (549,654) [2] (549,654)
Balance as at beginning (in shares) at Dec. 31, 2023 24,166,000   24,166,000 [2] 129,396,000 (105,230,000)              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Reverse recapitalization transaction, net of transaction costs and acquired liabilities $ 50,033   $ 2     50,031            
Reverse recapitalization transaction, net of transaction costs and acquired liabilities (in shares)     21,667,000                  
Stock-based compensation 1,223         1,223            
Foreign currency translation adjustment 1,064               1,064      
Net loss 757                   757  
Balance as at end at Mar. 31, 2024 (62,360)   $ 5     487,006     (474)   (548,897)  
Balance as at end (in shares) at Mar. 31, 2024     45,833,000                  
Balance as at beginning at Dec. 31, 2023 $ (115,437) [2] $ (115,437) $ 3 [2] $ 129 $ (126) 435,752 [2] $ 435,626 $ 126 (1,538) [2] $ (1,538) (549,654) [2] $ (549,654)
Balance as at beginning (in shares) at Dec. 31, 2023 24,166,000   24,166,000 [2] 129,396,000 (105,230,000)              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock from option exercises (in shares) 117,670                      
Issuance of commitment shares in connection with common stock purchase agreement (in shares) 56,818                      
Foreign currency translation adjustment $ 592                      
Net loss (7,407)                      
Balance as at end at Sep. 30, 2024 $ (58,251)   $ 5     499,751     (946)   (557,061)  
Balance as at end (in shares) at Sep. 30, 2024 47,611,000   47,611,000                  
Balance as at beginning at Mar. 31, 2024 $ (62,360)   $ 5     487,006     (474)   (548,897)  
Balance as at beginning (in shares) at Mar. 31, 2024     45,833,000                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock under common stock purchase agreement $ 3,388         3,388            
Issuance of common stock under common stock purchase agreement (in shares) 678,462   679,000                  
Issuance of commitment shares in connection with common stock purchase agreement (in shares)     57,000                  
Issuance of common stock to underwriter $ 667         667            
Issuance of common stock to underwriter (in shares)     110,000                  
Stock-based compensation 323         323            
Foreign currency translation adjustment 708               708      
Net loss (1,043)                   (1,043)  
Balance as at end at Jun. 30, 2024 (58,317)   $ 5     491,384     234   (549,940)  
Balance as at end (in shares) at Jun. 30, 2024     46,679,000                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Issuance of common stock from option exercises 13         13            
Issuance of common stock from option exercises (in shares)     118,000                  
Issuance of common stock under common stock purchase agreement $ 5,541         5,541            
Issuance of common stock under common stock purchase agreement (in shares) 1,421,715   1,422,000                  
Issuance of common stock and common stock warrants in a private placement $ 2,240         2,240            
Issuance of common stock and common stock warrants in a private placement (in shares)     742,000                  
Forfeiture of unvested sponsor earnout shares (in shares)     (1,350,000)                  
Stock-based compensation 573         573            
Foreign currency translation adjustment (1,180)               (1,180)      
Net loss (7,121)                   (7,121)  
Balance as at end at Sep. 30, 2024 $ (58,251)   $ 5     $ 499,751     $ (946)   $ (557,061)  
Balance as at end (in shares) at Sep. 30, 2024 47,611,000   47,611,000                  
[1] Amounts as of December 31, 2023 and before that date differ from those in prior year consolidated financial statements as they were retrospectively adjusted as a result of the accounting for the Business Combination (as defined in the Notes to the Unaudited Condensed Consolidated Financial Statements).
[2] Amounts as of December 31, 2023 and before that date differ from those in prior year consolidated financial statements as they were retrospectively adjusted as a result of the accounting for the Business Combination (as defined in the Notes to the Unaudited Condensed Consolidated Financial Statements).